Comparing effect of oral omeprazole versus intravenous pantaprazole in peptic ulcer bleeding

Not Applicable

• Conditions: Peptic ulcer, bleeding.; Peptic ulcer, site unspecified; K-27.0

• Registration Number: IRCT138711191650N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

INCLUSION CRITERIA ;All patient who admite in hospital due to GI bleeding and have high risk ulcer in endoscopic evaluation.
EXCLUSION CRITERIA ;Any patient who find to have esophageal varices ,bleeding tendency ,GI cancer ,uremia or Mallory Weiss tear.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recurrent bleeding. Timepoint: daily up to discharge and after 14 days. Method of measurement: hypotension,tachucardia ,Hb drop ,hematemesis after stabilization and recurrence of melena after normal stool.;Surgery. Timepoint: daily up to discharge and after 14 days. Method of measurement: daily up to discharge and phone call after 2 weeks.;Mortality (All cause ). Timepoint: daily up to discharge. Method of measurement: daily up to discharge and phone call after 2 weeks.

Secondary Outcome Measures

Name	Time	Method
Blood transfusion. Timepoint: during discharge. Method of measurement: number of transfused blood packed cells.;Hospital stay. Timepoint: daily. Method of measurement: assess during discharge.